41 KB481 KB38 KB192920262010Matičič, MojcaPoljak, Mario10 straniletnik:79številka:9str. 599-608ISSN:1318-0347COBISSID:27388889URN:URN:NBN:SI:doc-2MZKMO6OslSlovensko zdravniško društvoZdravniški vestnikChemopreventionHepatitis BImmunosuppressive AgentsImunosupresiviKemoprevencijanacionalne smernicePractice GuidelinesPraktična navodilareaktivacijatherapyVirus ActivationVirusna aktivacijavirusne infekcijezdravljenjeSlovenske nacionalne usmeritve za preprečevanje reaktivacije hepatitisa B pri bolnikih, ki potrebujejo imunosupresivno zdravljenje| Slovene national guidelines for the prevention of hepatitis B reactivation in patients undergoing immunosuppressive therapy|Chronic hepatitis B virus infection as well as the presence of a past viral infection may lead to the reactivation of hepatitis B in patients undergoing immunosuppressive therapy due to some underlying diseases. Prompt introductionof a preemptive treatment or chemoprophylaxis may successfully prevent the viral reactivation. For that reason, screening for hepatitis B virus infection prior to the introduction of immunosuppressive therapy is crucial for the management of hepatitis B reactivation. The pathogenesis, riskfactors and clinical course of hepatitis B reactivation in patients undergoing immunosuppressive therapy, as well as antiviral agents and the national guidelines for its prevention are presentedTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaSlovensko zdravniško društvo